Description
Dasatib 50mg Tablet is a targeted therapy medication used in the treatment of certain types of cancer, primarily chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Its active ingredient, Dasatinib, is a tyrosine kinase inhibitor (TKI). It works by blocking the activity of specific enzymes (tyrosine kinases) that are involved in the growth and proliferation of cancer cells. By inhibiting these enzymes, Dasatib helps to slow down or stop the growth of cancerous tumors and can lead to a reduction in cancer cell numbers. This medication is typically prescribed by a qualified oncologist and the dosage is determined based on the specific type and stage of cancer being treated, as well as the patient’s individual response and tolerance. Common side effects may include diarrhea, nausea, rash, fatigue, headache, muscle pain, and fluid retention. It is important to discuss any potential side effects with your healthcare provider. Dasatib 50mg Tablets should be stored at room temperature, away from moisture and heat, and out of reach of children.
